Evidence map›Paper›PMID 37284569›Full record

ReviewSAGE open medicine2023

Utility of chest imaging in the diagnosis and management of patients with visceral leishmaniasis: A systematic review.

Tesfahunegn Hailemariam, Yonas Mebratu, Tsion Andrias, Fikremariam Melkeneh, Abel Abebe, Biruk Mulualem, Zewdu Abadi, Wazema Desta, Selamawit Bedasso, Fekadu Belay and 6 more

Open access · goldAbstract readReview
In one paragraph

Review in SAGE open medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 3 countries.

Tesfahunegn HailemariamCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID https://orcid.org/0000-0003-4304-804X
Yonas MebratuLondon School of Hygiene & Tropical Medicine, London, UK.
Tsion AndriasPrivate Hospitals Association, Addis Ababa, Ethiopia.
Fikremariam MelkenehClinical Governance and Quality Improvement Unit, Teklehaimanot General Hospital, Addis Ababa, Ethiopia.ORCID https://orcid.org/0000-0003-3581-5464
Abel AbebeDetroit Medical Center/Wayne State University, Sinai Grace Hospital, Detroit, MI, USA.
Biruk MulualemDepartment of Radiology, College of Medicine and Health Sciences, Bahir Dar University, Bahirdar, Ethiopia.
Zewdu AbadiJinka General Hospital, Jinka, Ethiopia.
Wazema DestaHealth Policy Department, Health Professionals Network for Tigray Takoma Park, MD, USA.
Selamawit BedassoALERT Hospital/Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Fekadu BelayDepartment of Pediatrics and Child Health, College of Medicine and Health Sciences, Wachemo University, Hossana, Ethiopia.
Abibual SileshiInfectious Diseases Unit, Amdework Primary Hospital, Wag Hemra Zone, Ethiopia.
Elilta DestaPark Pediatrics Clinic, Takoma Park, MD, USA.
Felipe Velsaquez-BoteroLarkin Community Hospital, CES University, Miami, FL, USA.ORCID https://orcid.org/0000-0002-1353-0428
Rahel BirhaneCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Francesco MarinucciInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
Tsegahun ManyazewalCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Addis Ababa University · ETAll Africa Leprosy Tuberculosis and Rehabilitation Training Centre · ETAmhara Regional Health Bureau · ETBahir Dar University · ETEthiopian Public Health Association · ETLarkin Community Hospital · USLondon School of Hygiene & Tropical Medicine · GBUniversity of Maryland, Baltimore · USWayne State University · USWollo University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Visceral leishmaniasis remains a deadly parasitic disease with diagnostic complexities. Currently, point-of-care chest imaging is gaining momentum in the diagnosis of infectious diseases. Respiratory symptoms are common in visceral leishmaniasis. Here we aimed to systematically synthesize the evidence on the utility of chest imaging on the diagnosis and management of patients with visceral leishmaniasis. Methods: We searched PubMed, Scopus, Web of Science, ScienceDirect, and Google Scholar databases for studies reporting chest imaging findings in patients with visceral leishmaniasis, published in English from database inception to November 2022. We used the Joanna Briggs Institute checklists to evaluate the risk of bias. The protocol of this systematic review was registered with the Open Science Framework: https://doi.org/10.17605/OSF.IO/XP24W. Results: Of 1792 studies initially retrieved, 17 studies with 59 participants were included. Of the 59 patients, 51% (30) had respiratory symptoms and 20% (12) were human immunodeficiency virus co-infected. Chest X-ray, high-resolution computed tomography, and chest ultrasound findings were available for 95% (56), 93% (55), and 2% (1) of the patients, respectively. The most common findings were pleural effusion (20%; 12), reticular opacities (14%; 8), ground-glass opacities (12%; 7), and mediastinal lymphadenopathies (10%; 6). High-resolution computed tomography was more sensitive than chest X-ray and detected lesions that were lost on chest X-ray, 62% (37) versus 29% (17). In almost all cases, regression of the lesions was observed with treatment. Microscopy of pleural or lung biopsy detected amastigotes. Polymerase chain reaction yield was better in pleural and bronchoalveolar lavage fluids. A parasitological diagnosis from pleural and pericardial fluid was possible in AIDS patients. Overall, the risk of bias was low. Conclusions: Visceral leishmaniasis patients frequently had abnormal findings on high-resolution computed tomography. Chest ultrasound is a useful alternative in resource-limited settings to aid in diagnosis and subsequent treatment follow-up, especially when routine tests yield negative results despite clinical suspicion.

Indexed as

chest ultrasoundchest X-raydiagnostic imaginghigh-resolution computed tomographypoint-of-care ultrasoundtropical diseasesVisceral leishmaniasis

Identifiers

PMID37284569
PMCPMC10240871
OpenAlexW4379598642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.